Vancomycin(VM) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Vancomycin(VM) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-38-1 | 1. BSA-Vancomycin(VM) 2. Anti-Vancomycin(VM) mouse monoclonal antibody | $2709.00 |
GMP-SMT-38-2 | 1. OVA-Vancomycin(VM) 2. Anti-Vancomycin(VM) mouse monoclonal antibody | $2709.00 |
GMP-SMT-38-3 | 1. BSA-Vancomycin(VM) 2. Anti-Vancomycin(VM) human monoclonal antibody | $2709.00 |
GMP-SMT-38-4 | 1. OVA-Vancomycin(VM) 2. Anti-Vancomycin(VM) human monoclonal antibody | $2709.00 |
GMP-SMT-38-Ag-1 | BSA-Vancomycin(VM) | $756.00 |
GMP-SMT-38-Ag-2 | OVA-Vancomycin(VM) | $756.00 |
GMP-SMT-38-Ab-1 | Anti-Vancomycin(VM) mouse monoclonal antibody | $1953.00 |
GMP-SMT-38-Ab-2 | Anti-Vancomycin(VM) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Vancomycin(VM)
Cat No. | GMP-SMT-38-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Vancomycin(VM) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Vancomycin(VM) had been validated with our anti-Hapten antibody Anti-Vancomycin(VM) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Vancomycin(VM)
Cat No. | GMP-SMT-38-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Vancomycin(VM) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Vancomycin(VM) had been validated with our anti-Hapten antibody Anti-Vancomycin(VM) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Vancomycin(VM) mouse monoclonal antibody
Cat No. | GMP-SMT-38-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.8-1 |
Products description | The anti-Hapten antibody against hapten Vancomycin(VM) had been validated with our hapten hapten-carrier conjugates BSA-Vancomycin(VM) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Vancomycin(VM) human monoclonal antibody
Cat No. | GMP-SMT-38-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.8-1 |
Products description | The anti-Hapten antibody against hapten Vancomycin(VM) had been validated with our hapten hapten-carrier conjugates BSA-Vancomycin(VM) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1.Vancomycin (VM) in Veterinary Drug Residue Control and Monitoring
Vancomycin (VM), a glycopeptide antibiotic known for its potent activity against Gram-positive bacteria, is predominantly used in human medicine. However, its role extends beyond the confines of clinical practice and permeates into the realm of veterinary drug residue control and monitoring. In this comprehensive exploration, we delve into the scientific intricacies of Vancomycin's role in the veterinary context.
1.1 The Nature and Mechanism of Vancomycin
Vancomycin, first isolated from the bacterium Streptomyces orientalis, exerts its antibacterial effects by inhibiting cell wall synthesis in susceptible microorganisms. This mechanism of action makes it highly effective against a wide range of Gram-positive pathogens, including Staphylococcus and Streptococcus species. Its unique structure and mode of action render it a critical tool in treating severe bacterial infections, particularly those that have developed resistance to other antibiotics.
1.2 The Role of Vancomycin in Veterinary Medicine
While Vancomycin is not directly administered as a veterinary drug to animals, its importance in veterinary medicine lies in its application as a control substance for quality assurance and safety checks in the production of animal-derived products. These products, such as meat, milk, and eggs, are destined for human consumption, necessitating rigorous scrutiny to ensure their freedom from harmful residues, including antibiotics like Vancomycin.
2.The Significance of Measuring Vancomycin (VM) in Veterinary Medicine
The measurement of Vancomycin (VM) in veterinary medicine holds paramount importance, both from a scientific and regulatory perspective.
2.1 Residue Monitoring
Vancomycin can leave residual traces in animal tissues and their derived products if administered inappropriately or excessively in animal husbandry. These residues can pose a potential risk to consumers, particularly when ingested through animal-derived foods. Rigorous monitoring of Vancomycin levels is essential to ensure compliance with safety regulations, ultimately safeguarding public health.
2.2 Antibiotic Resistance Surveillance
The burgeoning concern of antibiotic resistance in both human and veterinary medicine is intricately linked to the overutilization of antibiotics in animal husbandry. Vancomycin, as a widely-used antibiotic, is of particular interest in this context. The precise measurement of Vancomycin in animal populations assists in assessing its usage and its potential contribution to the development of antibiotic resistance. This surveillance is crucial for designing effective strategies to combat the growing challenge of antibiotic-resistant pathogens.
2.3 Regulatory Compliance
Government agencies and food safety organizations have stipulated maximum residue limits (MRLs) for Vancomycin in various animal products. These limits are established to safeguard public health and ensure the safety of consumers. Routine measurements of Vancomycin are indispensable to ascertain adherence to these limits and to uphold regulatory standards. Ensuring that animal products meet or fall below these specified limits is essential to prevent the consumption of harmful levels of Vancomycin.
2.4 Consumer Health and Safety
Ultimately, the precise measurement of Vancomycin in animal-derived products is fundamental to safeguarding consumer health and safety. Ensuring that Vancomycin residues remain within safe limits is critical in preventing adverse health effects in those who consume these products. High levels of Vancomycin in animal-derived foods can lead to health risks, making it imperative to maintain stringent monitoring practices.
In conclusion, the role of Vancomycin in veterinary drug residue control and monitoring is of utmost significance in ensuring the safety of animal-derived products, mitigating antibiotic resistance, and guaranteeing strict compliance with regulatory standards. The scientific measurement and surveillance of Vancomycin in the veterinary context underscore its importance as a pivotal component of public health and safety protocols.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.